Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Published on 05 Feb 2020

Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-Making

in Drugs Outcomes Research and Policies

Robbe Saesen
Stéphane Lejeune
Gianluca Quaglio
Denis Lacombe
Isabelle Huys

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00043

8,623 views
17 citations

Policy and Practice Reviews

Published on 03 Feb 2020

Evaluation of the Performance of the Turkish Regulatory Agency: Recommendations for Improved Patients’ Access to Medicines

in Drugs Outcomes Research and Policies

Oguzhan Koyuncu
Hakki Gursoz
Ali Alkan
Hacer Coskun Cetintas
Tuncay Pasaoglu
Emel Mashaki Ceyhan
Stuart Walker

Frontiers in Pharmacology

doi 10.3389/fphar.2019.01557

7,896 views
1 citation

Policy and Practice Reviews

Published on 31 Jan 2020

On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients

in Drugs Outcomes Research and Policies

Ciska Verbaanderd
Ilse Rooman
Lydie Meheus
Isabelle Huys

Frontiers in Pharmacology

doi 10.3389/fphar.2019.01664

14,111 views
56 citations

Systematic Review

Published on 31 Jan 2020

Fatal Adverse Events Associated With Programmed Cell Death Ligand 1 Inhibitors: A Systematic Review and Meta-Analysis

in Drugs Outcomes Research and Policies

Xuewen Wang
Shijie Wu
Yaying Chen
Erqian Shao
Tingting Zhuang
Linbin Lu
Xiong Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00005

4,633 views
13 citations

Original Research

Published on 30 Jan 2020

Psychotropic Polypharmacy in Adults 55 Years or Older: A Risk for Impaired Global Cognition, Executive Function, and Mobility

in Drugs Outcomes Research and Policies

Gilles Loggia
Elpidio Attoh-Mensah
Kristell Pothier
Rémy Morello
Pascale Lescure
Marie-Laure Bocca
Christian Marcelli
Chantal Chavoix

Frontiers in Pharmacology

doi 10.3389/fphar.2019.01659

5,947 views
23 citations

Original Research

Published on 30 Jan 2020

Implementation of a Physiologically Based Pharmacokinetic Modeling Approach to Guide Optimal Dosing Regimens for Imatinib and Potential Drug Interactions in Paediatrics

in Drugs Outcomes Research and Policies

Jeffry Adiwidjaja
Alan V. Boddy
Andrew J. McLachlan

Frontiers in Pharmacology

doi 10.3389/fphar.2019.01672

9,835 views
36 citations

Systematic Review

Published on 28 Jan 2020

Efficacy of Chemotherapies and Stem Cell Transplantation for Systemic AL Amyloidosis: A Network Meta-Analysis

in Drugs Outcomes Research and Policies

Yuwen Cai
Shizhang Xu
Na Li
Song Li
Gaosi Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2019.01601

4,241 views
4 citations

Systematic Review

Published on 24 Jan 2020

Efficacy and Safety of Rimegepant for the Acute Treatment of Migraine: Evidence From Randomized Controlled Trials

in Drugs Outcomes Research and Policies

Bixi Gao
Yanbo Yang
Zilan Wang
Yue Sun
Zhouqing Chen
Yun Zhu
Zhong Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2019.01577

22,911 views
40 citations

Policy and Practice Reviews

Published on 21 Jan 2020

Knowledge Translation for Improving the Care of Deinstitutionalized People With Severe Mental Illness in Health Policy

in Drugs Outcomes Research and Policies

Izabela Fulone
Jorge Otavio Maia Barreto
Silvio Barberato-Filho
Marcel Henrique de Carvalho
Luciane Cruz Lopes

Frontiers in Pharmacology

doi 10.3389/fphar.2019.01470

3,956 views
2 citations

Original Research

Published on 17 Jan 2020

The Risks and Outcomes Resulting From Medication Errors Reported in the Finnish Tertiary Care Units:

in Drugs Outcomes Research and Policies

Outi Laatikainen
Sami Sneck
Miia Turpeinen

Frontiers in Pharmacology

doi 10.3389/fphar.2019.01571

15,804 views
14 citations

Original Research

Published on 16 Jan 2020

Cost-Utility Analysis of Incobotulinumtoxin-A Compared With Conventional Therapy in the Management of Post-Stroke Spasticity in Romania

in Drugs Outcomes Research and Policies

Adina Turcu-Stiolica
Mihaela-Simona Subtirelu
Ana-Maria Bumbea

Frontiers in Pharmacology

doi 10.3389/fphar.2019.01516

3,267 views
4 citations

Systematic Review

Published on 15 Jan 2020

Meta-Analysis of Randomized Controlled Trials Using Botulinum Toxin A at Different Dosages for Urinary Incontinence in Patients With Overactive Bladder

in Drugs Outcomes Research and Policies

Qin-Qin Gong
Yu-Qiong Xu
Jun Xu
Xiao-Yan Ding
Chong Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2019.01618

5,129 views
18 citations

Original Research

Published on 15 Jan 2020

Relationship Between Medication Literacy and Medication Adherence in Inpatients With Coronary Heart Disease in Changsha, China

in Drugs Outcomes Research and Policies

Feng Zheng
Siqing Ding
Lin Lai
Xiaoqing Liu
Yinglong Duan
Shuangjiao Shi
Zhuqing Zhong

Frontiers in Pharmacology

doi 10.3389/fphar.2019.01537

6,408 views
34 citations

Perspective

Published on 15 Jan 2020

Evolution of Ethical Principles in the Practice of Pharmaceutical Medicine From a UK Perspective

in Drugs Outcomes Research and Policies

Thomas Morris
Joshua M. Brostoff
Peter David Stonier
Alan Boyd

Frontiers in Pharmacology

doi 10.3389/fphar.2019.01525

8,480 views
5 citations

Original Research

Published on 10 Jan 2020

Validation and Reliability of Healthcare Workers’ Knowledge, Attitude, and Practice Instrument for Uncomplicated Malaria by Rasch Measurement Model

in Drugs Outcomes Research and Policies

Nahlah E. Ismail
Nanloh S. Jimam
Maxwell L. P. Dapar
Sohail Ahmad

Frontiers in Pharmacology

doi 10.3389/fphar.2019.01521

5,097 views
15 citations

Original Research

Published on 10 Jan 2020

Perspective of Key Healthcare Professionals on Antimicrobial Resistance and Stewardship Programs: A Multicenter Cross-Sectional Study From Pakistan

in Drugs Outcomes Research and Policies

Khezar Hayat
Meagen Rosenthal
Ali Hassan Gillani
Jie Chang
Wenjing Ji
Caijun Yang
Minghuan Jiang
Mingyue Zhao
Yu Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2019.01520

9,122 views
47 citations

Navigation group

Articles

Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-Making

Evaluation of the Performance of the Turkish Regulatory Agency: Recommendations for Improved Patients’ Access to Medicines

On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients

Fatal Adverse Events Associated With Programmed Cell Death Ligand 1 Inhibitors: A Systematic Review and Meta-Analysis

Psychotropic Polypharmacy in Adults 55 Years or Older: A Risk for Impaired Global Cognition, Executive Function, and Mobility

Implementation of a Physiologically Based Pharmacokinetic Modeling Approach to Guide Optimal Dosing Regimens for Imatinib and Potential Drug Interactions in Paediatrics

Efficacy of Chemotherapies and Stem Cell Transplantation for Systemic AL Amyloidosis: A Network Meta-Analysis

Efficacy and Safety of Rimegepant for the Acute Treatment of Migraine: Evidence From Randomized Controlled Trials

Knowledge Translation for Improving the Care of Deinstitutionalized People With Severe Mental Illness in Health Policy

The Risks and Outcomes Resulting From Medication Errors Reported in the Finnish Tertiary Care Units:

Cost-Utility Analysis of Incobotulinumtoxin-A Compared With Conventional Therapy in the Management of Post-Stroke Spasticity in Romania

Meta-Analysis of Randomized Controlled Trials Using Botulinum Toxin A at Different Dosages for Urinary Incontinence in Patients With Overactive Bladder

Relationship Between Medication Literacy and Medication Adherence in Inpatients With Coronary Heart Disease in Changsha, China

Evolution of Ethical Principles in the Practice of Pharmaceutical Medicine From a UK Perspective

Validation and Reliability of Healthcare Workers’ Knowledge, Attitude, and Practice Instrument for Uncomplicated Malaria by Rasch Measurement Model

Perspective of Key Healthcare Professionals on Antimicrobial Resistance and Stewardship Programs: A Multicenter Cross-Sectional Study From Pakistan